234 related articles for article (PubMed ID: 31189114)
1. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy.
Celis-Gutierrez J; Blattmann P; Zhai Y; Jarmuzynski N; Ruminski K; Grégoire C; Ounoughene Y; Fiore F; Aebersold R; Roncagalli R; Gstaiger M; Malissen B
Cell Rep; 2019 Jun; 27(11):3315-3330.e7. PubMed ID: 31189114
[TBL] [Abstract][Full Text] [Related]
2. PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2.
Xu X; Hou B; Fulzele A; Masubuchi T; Zhao Y; Wu Z; Hu Y; Jiang Y; Ma Y; Wang H; Bennett EJ; Fu G; Hui E
J Cell Biol; 2020 Jun; 219(6):. PubMed ID: 32437509
[TBL] [Abstract][Full Text] [Related]
3. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2.
Gavrieli M; Watanabe N; Loftin SK; Murphy TL; Murphy KM
Biochem Biophys Res Commun; 2003 Dec; 312(4):1236-43. PubMed ID: 14652006
[TBL] [Abstract][Full Text] [Related]
4. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation.
Chemnitz JM; Parry RV; Nichols KE; June CH; Riley JL
J Immunol; 2004 Jul; 173(2):945-54. PubMed ID: 15240681
[TBL] [Abstract][Full Text] [Related]
5. THEMIS promotes T cell development and maintenance by rising the signaling threshold of the inhibitory receptor BTLA.
Mélique S; Vadel A; Rouquié N; Yang C; Bories C; Cotineau C; Saoudi A; Fazilleau N; Lesourne R
Proc Natl Acad Sci U S A; 2024 May; 121(20):e2318773121. PubMed ID: 38713628
[TBL] [Abstract][Full Text] [Related]
6. Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors.
Xu X; Masubuchi T; Cai Q; Zhao Y; Hui E
Elife; 2021 Nov; 10():. PubMed ID: 34734802
[TBL] [Abstract][Full Text] [Related]
7. B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs.
Chemnitz JM; Lanfranco AR; Braunstein I; Riley JL
J Immunol; 2006 Jun; 176(11):6603-14. PubMed ID: 16709818
[TBL] [Abstract][Full Text] [Related]
8. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.
Watanabe N; Gavrieli M; Sedy JR; Yang J; Fallarino F; Loftin SK; Hurchla MA; Zimmerman N; Sim J; Zang X; Murphy TL; Russell JH; Allison JP; Murphy KM
Nat Immunol; 2003 Jul; 4(7):670-9. PubMed ID: 12796776
[TBL] [Abstract][Full Text] [Related]
9. Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond.
Ai L; Xu A; Xu J
Adv Exp Med Biol; 2020; 1248():33-59. PubMed ID: 32185706
[TBL] [Abstract][Full Text] [Related]
10. SHP-1 phosphatase activity counteracts increased T cell receptor affinity.
Hebeisen M; Baitsch L; Presotto D; Baumgaertner P; Romero P; Michielin O; Speiser DE; Rufer N
J Clin Invest; 2013 Mar; 123(3):1044-56. PubMed ID: 23391724
[TBL] [Abstract][Full Text] [Related]
11. PD-1/SHP-2 inhibits Tc1/Th1 phenotypic responses and the activation of T cells in the tumor microenvironment.
Li J; Jie HB; Lei Y; Gildener-Leapman N; Trivedi S; Green T; Kane LP; Ferris RL
Cancer Res; 2015 Feb; 75(3):508-518. PubMed ID: 25480946
[TBL] [Abstract][Full Text] [Related]
12. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
Frearson JA; Alexander DR
J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells.
Bardhan K; Aksoylar HI; Le Bourgeois T; Strauss L; Weaver JD; Delcuze B; Charest A; Patsoukis N; Boussiotis VA
Sci Rep; 2019 Nov; 9(1):17252. PubMed ID: 31754127
[TBL] [Abstract][Full Text] [Related]
14. HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors.
Kinosada H; Yasunaga JI; Shimura K; Miyazato P; Onishi C; Iyoda T; Inaba K; Matsuoka M
PLoS Pathog; 2017 Jan; 13(1):e1006120. PubMed ID: 28046066
[TBL] [Abstract][Full Text] [Related]
15. Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation.
Patsoukis N; Duke-Cohan JS; Chaudhri A; Aksoylar HI; Wang Q; Council A; Berg A; Freeman GJ; Boussiotis VA
Commun Biol; 2020 Mar; 3(1):128. PubMed ID: 32184441
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection.
Zhang J; Somani AK; Yuen D; Yang Y; Love PE; Siminovitch KA
J Immunol; 1999 Sep; 163(6):3012-21. PubMed ID: 10477564
[TBL] [Abstract][Full Text] [Related]
17. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.
Yokosuka T; Takamatsu M; Kobayashi-Imanishi W; Hashimoto-Tane A; Azuma M; Saito T
J Exp Med; 2012 Jun; 209(6):1201-17. PubMed ID: 22641383
[TBL] [Abstract][Full Text] [Related]
18. TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1.
Johnson KG; LeRoy FG; Borysiewicz LK; Matthews RJ
J Immunol; 1999 Apr; 162(7):3802-13. PubMed ID: 10201897
[TBL] [Abstract][Full Text] [Related]
19. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
[TBL] [Abstract][Full Text] [Related]
20. Constitutive association of SHP-1 with leukocyte-associated Ig-like receptor-1 in human T cells.
Sathish JG; Johnson KG; Fuller KJ; LeRoy FG; Meyaard L; Sims MJ; Matthews RJ
J Immunol; 2001 Feb; 166(3):1763-70. PubMed ID: 11160222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
